One hundred cases of primary pterygium were treated with conjunctival autograft and Mitomycin C 0.02% intra-operatively for 5 minutes at the bare sclera by cotton swab. Anesthesia used was topical proparacaine and local infiltration of lignocaine. Patients were followed postoperatively for 9-12 months to find the recurrence (defined as fibrovascular tissues invading the cornea 1mm or more) of pterygium and complications. All surgeries were performed by one surgeon. RESULTS: Of the hundred cases 17 were lost in follow-up. In remaining eighty-three eyes received conjunctival autograft (CAG n=52) and Mitomycin C (MMC n=31). There were 4 (7.69%) recurrences in group A (CAG) and 8 (16.13%) recurrences in group B (MMC). There was statistically significant difference in the recurrence rate between the two groups. The post operative complications in MMC group were two punctate epithelial keratitis, one conjunctival granuloma and one has dellen. No significant complications were encountered in conjunctival autograft group. CONCLUSION: Simple excision of pterygium followed by conjunctival autograft has the lowest recurrence rate and minimal incidence of complications as compared to intraoperative Mitomycin C.
INTRODUCTION
Pterygium is a fibrovascular wing shaped encroachment of conjunctiva on to the cornea 1 . It is more frequent in areas with more ultraviolet radiation, 2 especially UVR-A and UVR-B (290-400nm) is considered the most dangerous 3, 4 . It is also more frequent in hot, dry, windy, dusty and smoky environments 5, 6 . There is also a hereditary factor 7 . The complaints which it may give rise are foreign body feeling, visual loss due to corneal astigmatism or cosmetic problems 8 . Though anti-inflammatory drugs and lubricants have an important role in minimizing the patients discomfort but do not cure the disease. The excision of a pterygium with bare sclera was widely practiced because it was believed to be safe and simple. However, with time it becomes apparent that the recurrence rate was unacceptably high ranging from 24% to 89% 9 . Several methods were implemented with the aim of improving the success rate, among them transplantation of the head of the pterygium, conjunctival flaps, lamellar keratoplasty, mucous membrane grafts, chemotherapy by Thiotepa, radiation therapy by radon bulbs, radium plaques, beta irradiation ablation with erbium YAG laser 10 and smoothening the corneal surface with excimer laser 11 has been tried. Several of them succeeded in lowering the recurrence rates but did so at the price of sight-threatening complications from the tissue damage associated with the treatment 12 . However, autologous conjunctival grafting seems to be the best method, giving both low recurrence rate and high safety 13, 14 . Kenyon et al, 15 first described a conjunctival autograft in 1985. They documented a recurrence rate of 5.3% and infrequent minor complications. Since then, the other authors also reported that autologous conjunctival grafting seems to the best method giving both low recurrence rate and high safety 13, 16 . The primary disadvantage of this technique is prolonged operative time required when compared to the bare sclera technique. These disadvantages are out weighed 12 . Unitomo, and Nori 16 were the first to report the promising effect of Mitomycin C
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Ashok Kumar Narsani, Shafi Muhammad Jatoi, Siddiqa Gul and Syed Asher Dabir on the recurrence of pterygium. Mitomycin C is an alkylating antineoplastic agent produced by strains of streptomyces caespinosus, which inhibits synthesis of DNA, RNA and proteins 17 . The current regime of Mitomycin C is 0.02 % to the bare sclera for 5 minutes has been found efficient in reducing the recurrence rate to a minimum [18] [19] [20] . In our study, we compared the recurrence rate of two different techniques.
MATERIALS & METHODS
Hundred cases of primary pterygium were registered at the tertiary referral center, Department of Ophthalmology, Liaquat University of Medical & Health Sciences, Jamshoro / Hyderabad. Patients were randomized in to two groups. Group A (received conjuctival autograft) and Group B (received intraoperative 0.02% Mitomycin C). These patients had been questioned and medical data reviewed in details that none had major systemic disease such as collagen vascular disorder, diabetes mellitus. Complete ocular examination including visual acuity, intraocular pressure, extraocular movements, biomicroscopy documentation of pterygeal size and dilated fundoscopy was performed to assure that none of them had major eye disease such as dry eye, cicatrical pemphigoid, glaucoma or vitreoretinal disease. All patients were followed for 6 to 12 months to assess the recurrence rate and complications. The ocular surface was anesthetized in all patients with topical instillation of proparacaine hydrochloride 0.5% in combination with an additional sub conjunctival injection in the bed of pterygium on the bulbar side with 0.5 ml of 2% lignocaine hydrochloride with 0.001% adrenaline. The complete excision of the head of the pterygium from the cornea was done by Bard Parker 15 number blade and the body of pterygium was dissected and excised by conjunctival scissors. In group A (CAG) area of the bare sclera was measured after pterygium excision. A free conjunctival graft was harvested from the superior conjunctiva. Dissection began from fornix to limbus.
The graft was flipped over on the cornea and tenons attachment at limbus was meticulously dissected. The flap was then excised taking care to include the limbal tissue. The graft was then moved on to the scleral bed maintaining limbus to limbus orientation. The four corners were anchored with episcleral bites using 8/0 vicryl suture. In group B (MMC) intraoperative Mitomycin C 0.02% was applied to the bare sclera for 5 minutes by cotton swab. The Mitomycin C was prepared by adding 10 ml of distilled water in 2 mg ampoule of injection. The site of application was then thoroughly irrigated with at least 100 ml of ringer lactate solution. The conjunctiva peripheral to the excised pterygium was undermined and the edges were sutured 2-3 mm from the limbus. Postoperative topical combination of corticosteroid antibiotic ointment was used and pad was applied for 24 hours. Antibiotic and corticosteroid were used 4 times a day for a month and then tapered off during the following 2-3 months. Follow-up visits were scheduled for post operative days 1,7,14, 30 and then every 2 months. The recurrence was defined as post operative fibro-vascular re-growth crossing the corneo-scleral limbus by 1.0 mm or more and this constituted treatment failure. All the information was filled on a profoma. Data were analyzed on SPSS version 10.0.
RESULTS
We studied the recurrence rate of two different surgical techniques for primary pterygium excision. The demographic and the clinical details are summarized in Table I . Out of a hundred cases eighty-three eyes (52 CAG, 31 MMC) of 76 patients (52 CAG, 24 MMC) were followed. The remaining 17 patients were lost in follow up. The recurrence in-group A was 7.69% whereas recurrence in group B was 16.13%. In-group A recurrences were, one within 2 months, two within 5-6 months and one within 9-10 months (Table II) . In group B recurrences were two within 3-4 months, two within 5-6 months and one within 9-10 months. The 
CAG = Conjunctival Autograft, MMC = Mitomycin C

Groups
With No of eyes difference in recurrence rate was statistically significant. No significant complications were noted in group A except varying level of discomfort, foreign body sensation tearing and redness for some period in few patients. There were two patients with punctate epithelial keratits, one granuloma and one dellen in group B. No scleral thinning, necrosis, perforation or any other visually significant complication was encountered in either group.
DISCUSSION
Various surgical techniques have been employed to treat the pterygium. The unpredictable rates and timing of recurrence 21 are the main problem encountered after various treatment modalities. A recurrent pterygium can be associated with decreased visual acuity due to involvement of visual axis and/or irregular astigmatism, extraocular motility restriction and symblepharon formation 22 . Because of high recurrence rate the bare sclera excision alone proved unsatisfactory. Adjunctive treatment after bare sclera excision with Beta irradiation reduced recurrence rate to as low as 0.5%-10% 23 , but was associated with significant complications such as scleral necrosis. In 1985, Kenayn et al 15 published report describing conjunctival autografting as a promising technique in the treatment of pterygium. They documented the recurrence rate of 5.3% in the primary pterygium group. Since then a number of papers on the success of conjunctival grafting have been published with various success rates. Compared with the bare sclera method, conjunctival autograft is more technically demanding procedure; surgeon factors such as experience, techniques, etc. may have a profound influence on the recurrence rate 15 . More over conjunctival grafts including limbal epithelium generally yield better results because it will help to restore its barrier function 24 . In 1998, Lewallen S 25 published report of a randomized trial of the conjunctival autografting technique for pterygium removal. She documented a lower recurrence rate (21 %) in grafted cases compared with bare sclera technique (37 %). Riodan-Eva et al 26 29 postoperative MMC, but neither showed any statistical difference. However these studies failed to show any difference between MMC and conjunctival autograft. The results of our study reported an advantage of conjunctival autograft over Mitomycin C. Our results are compatible with national and international studies.
CONCLUSION
Simple excision of pterygium followed by conjunctival autograft has the lowest recurrence rate and minimal incidence of complications as compared to intraoperative Mitomycin C. 
